UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized severe COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS) and death showed the drug to be safe and effective. The trial was halted early due to the (read more)
UTRF News
Employee Spotlight: Lakita Cavin
The University of Tennessee Research Foundation is grateful for the hard work and dedication of its employees. One valuable member of the UTRF team, Senior Staff Attorney Lakita Cavin at the UT Health Science Center Office, has left UTRF to accept a position with the Alzheimer’s Drug Discovery Foundation (ADDF) after fifteen years of (read more)
UTRF Partners with UTHSC College of Pharmacy to Teach Students about Pharmaceutical Commercialization
The University of Tennessee Research Foundation recently partnered with the University of Tennessee Health Science Center’s College of Pharmacy to establish a four-week rotation for pharmacy students to learn about pharmaceutical commercialization. This month, UTRF welcomed the program’s first two participants: third-year pharmacy students Imran Khan and Taylor Wisdom. During the rotation, students will learn (read more)